Plasma Amino Acids Metabolomics' Important in Glucose Management in Type 2 Diabetes

被引:32
|
作者
Alqudah, Abdelrahim [1 ]
Wedyan, Mohammed [2 ]
Qnais, Esam [2 ]
Jawarneh, Hassan [2 ]
McClements, Lana [3 ]
机构
[1] Hashemite Univ, Fac Pharmaceut Sci, Dept Clin Pharm & Pharm Practice, Zarqa, Jordan
[2] Hashemite Univ, Fac Sci, Dept Biol & Biotechnol, Zarqa, Jordan
[3] Univ Technol Sydney, Fac Sci, Sch Life Sci, Sydney, NSW, Australia
关键词
type; 2; diabetes; amino acids; metabolism; glucose; lipids; BRANCHED-CHAIN; INSULIN-RESISTANCE; RISK; PROFILE; BIOMARKERS; METFORMIN; COMPLICATIONS; POPULATION; ALANINE; LIPIDS;
D O I
10.3389/fphar.2021.695418
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The perturbation in plasma free amino acid metabolome has been observed previously in diabetes mellitus, and is associated with insulin resistance as well as the onset of cardiovascular disease in this population. In this study, we investigated, for the first time, changes in the amino acid profile in a group of people with and without type 2 diabetes (T2D) with normal BMI, from Jordan, who were only managed on metformin. Twenty one amino acids were evaluated in plasma samples from 124 people with T2D and 67 healthy controls, matched for age, gender and BMI, using amino acids analyser. Total amino acids, essential amino acids, non-essential amino acids and semi-essential amino acids were similar in T2D compared to healthy controls. Plasma concentrations of four essential amino acids were increased in the presence of T2D (Leucine, p < 0.01, Lysine, p < 0.001, Phenylalanine, p < 0.01, Tryptophan, p < 0.05). On the other hand, in relation to non-essential amino acids, Alanine and Serine were reduced in T2D (p < 0.01, p < 0.001, respectively), whereas Aspartate and Glutamate were increased in T2D compared to healthy controls (p < 0.001, p < 0.01, respectively). A semi-essential amino acid, Cystine, was also increased in T2D compared to healthy controls (p < 0.01). Citrulline, a metabolic indicator amino acid, demonstrated lower plasma concentration in T2D compared to healthy controls (p < 0.01). These amino acids were also correlated with fasting blood glucose and HbA1c (p < 0.05). Glutamate, glycine and arginine were correlated with the duration of metformin treatment (p < 0.05). No amino acid was correlated with lipid profiles. Disturbances in the metabolism of these amino acids are closely implicated in the pathogenesis of T2D and associated cardiovascular disease. Therefore, these perturbed amino acids could be explored as therapeutic targets to improve T2D management and prevent associated cardiovascular complications.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Surveillance of the liver in type 2 diabetes: important but unfeasible?
    Qadri, Sami
    Yki-Jarvinen, Hannele
    DIABETOLOGIA, 2024, 67 (06) : 961 - 973
  • [42] Increased Plasma Levels of Xanthurenic and Kynurenic Acids in Type 2 Diabetes
    Oxenkrug, Gregory F.
    MOLECULAR NEUROBIOLOGY, 2015, 52 (02) : 805 - 810
  • [43] Dietary protein, amino acids and type 2 diabetes mellitus: a short review
    Mensink, Marco
    FRONTIERS IN NUTRITION, 2024, 11
  • [44] The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well-controlled plasma LDL cholesterol
    Bouter, Kristien E. C.
    van Bommel, Erik J. M.
    Jansen, Hans
    van Harskamp, Dewi
    Schierbeek, Henk
    Ackermans, Mariette T.
    Serlie, Mireille J.
    Schimmel, Alinda W. M.
    Nieuwdorp, Max
    Dallinga-Thie, Geesje M.
    van Raalte, Daniel H.
    DIABETES OBESITY & METABOLISM, 2020, 22 (06) : 988 - 996
  • [45] Sodium-glucose cotransporter 2 inhibitors for the management of type 2 diabetes
    Siamashvili, Maka
    Davis, Stephen N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (16) : 2181 - 2198
  • [46] Serum bile acid response to oral glucose is attenuated in patients with early type 2 diabetes and correlates with 2-hour plasma glucose in individuals without diabetes
    Wang, Xuyi
    Chen, Chang
    Xie, Cong
    Huang, Weikun
    Young, Richard L.
    Jones, Karen L.
    Horowitz, Michael
    Rayner, Christopher K.
    Sun, Zilin
    Wu, Tongzhi
    DIABETES OBESITY & METABOLISM, 2022, 24 (06) : 1132 - 1142
  • [47] A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 Diabetes
    Damanhouri, Zoheir A.
    Alkreathy, Huda M.
    Alharbi, Fawaz A.
    Abualhamail, Haneen
    Ahmad, Muhammad S.
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2023, 20 (01): : 142 - 150
  • [48] Personalized Management of Type 2 Diabetes
    Peter, Patricia R.
    Lupsa, Beatrice C.
    CURRENT DIABETES REPORTS, 2019, 19 (11)
  • [49] Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults
    Qiu, Gaokun
    Zheng, Yan
    Wang, Hao
    Sun, Jie
    Ma, Hongxia
    Xiao, Yang
    Li, Yizhun
    Yuan, Yu
    Yang, Handong
    Li, Xiulou
    Min, Xinwen
    Zhang, Ce
    Xu, Chengwei
    Jiang, Yue
    Zhang, Xiaomin
    He, Meian
    Yang, Ming
    Hu, Zhibin
    Tang, Huiru
    Shen, Hongbing
    Hu, Frank B.
    Pan, An
    Wu, Tangchun
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2016, 45 (05) : 1507 - 1516
  • [50] Plasma branched chain/aromatic amino acids, enriched Mediterranean diet and risk of type 2 diabetes: case-cohort study within the PREDIMED Trial
    Ruiz-Canela, Miguel
    Guasch-Ferre, Marta
    Toledo, Estefania
    Clish, Clary B.
    Razquin, Cristina
    Liang, Liming
    Wang, Dong D.
    Corella, Dolores
    Estruch, Ramon
    Hernaez, Alvaro
    Yu, Edward
    Gomez-Gracia, Enrique
    Zheng, Yan
    Aros, Fernando
    Romaguera, Dora
    Dennis, Courtney
    Ros, Emilio
    Lapetra, Jose
    Serra-Majem, Lluis
    Papandreou, Christopher
    Portoles, Olga
    Fito, Montserrat
    Salas-Salvado, Jordi
    Hu, Frank B.
    Martinez-Gonzalez, Miguel A.
    DIABETOLOGIA, 2018, 61 (07) : 1560 - 1571